SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 94.15 |
Enterprise Value ($M) | 107.22 |
Book Value ($M) | -15.91 |
Book Value / Share | -0.21 |
Price / Book | -5.92 |
NCAV ($M) | -21.01 |
NCAV / Share | -0.28 |
Price / NCAV | -4.48 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.20 |
Return on Assets (ROA) | -0.73 |
Return on Equity (ROE) | -3.06 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.24 |
Current Ratio | 4.24 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 28.92 |
Assets | 34.02 |
Liabilities | 49.93 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 8.23 |
Operating Income | -24.84 |
Net Income | -32.48 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -18.14 |
Cash from Investing | -1.78 |
Cash from Financing | 0.41 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Whitmore Bradford T | 10.10 | 4.11 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
62,988 | 28,502 | 221.00 | |
18,961 | 23,724 | 79.92 | |
39,449 | 49,490 | 79.71 | |
114,517 | 32,954 | 347.51 | |
70,308 | 64,533 | 108.95 | |
(click for more detail) |
Similar Companies | |
---|---|
CARM – Carisma Therapeutics, Inc. | CGTX – Cognition Therapeutics, Inc. |
CHRS – Coherus BioSciences, Inc. | CMRX – Chimerix, Inc. |
CRMD – CorMedix Inc. |
Financial data and stock pages provided by
Fintel.io